郑州泰丰制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
33
NMPA:33
Drug Approvals
Baloxavir Marboxil Tablets
- Product Name
- 玛巴洛沙韦片
- Approval Number
- 国药准字H20253114
- Approval Date
- Jan 8, 2025
NMPA
Cinacalcet Hydrochloride Tablets
- Product Name
- 盐酸西那卡塞片
- Approval Number
- 国药准字H20233843
- Approval Date
- Jun 30, 2023
NMPA
Metformin Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸二甲双胍缓释片
- Approval Number
- 国药准字H20090120
- Approval Date
- Mar 30, 2023
NMPA
Compound Guaiacol Potassium Sulfonale Oral Solution
- Product Name
- 复方愈创木酚磺酸钾口服溶液
- Approval Number
- 国药准字H41024903
- Approval Date
- Mar 15, 2023
NMPA
Pediatric Compound Ephedr ine Hydrochloride and Bal loonflower Syrup
- Product Name
- 小儿复方麻黄碱桔梗糖浆
- Approval Number
- 国药准字H41024905
- Approval Date
- Mar 15, 2023
NMPA
Omeprazole Enteric Capsules
- Product Name
- 奥美拉唑肠溶胶囊
- Approval Number
- 国药准字H20084515
- Approval Date
- Mar 15, 2023
NMPA
Oral Rehydration Salts Powder(Ⅱ）
- Product Name
- 口服补液盐散(Ⅱ)
- Approval Number
- 国药准字H41024244
- Approval Date
- Jan 11, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found